BRAF mutational status as a prognostic marker for survival in malignant melanoma: a systematic review and meta-analysis von Ny, L., Hernberg, M., Nyakas, M., Koivunen, J., Oddershede, L., Yoon, M., Wang, X., Guyot, P., Geisler, J.

Volltext

Increased incidence of melanoma in children and adolescents in Finland in 1990-2014: nationwide re-evaluation of histopathological characteristics von Rousi, Emma K., Kallionpää, Roope A., Kallionpää, Roosa E., Juteau, Susanna M., Talve, Lauri A. I., Hernberg, Micaela M., Vihinen, Pia P., Kähäri, Veli-Matti, Koskivuo, Ilkka O.

Volltext

Metastatic uveal melanoma managed with best supportive care von Rantala, Elina S., Hernberg, Micaela M., Lundin, Mikael, Lundin, Johan, Kivelä, Tero T.

Volltext

Metastatic uveal melanoma: The final frontier von Rantala, Elina S., Hernberg, Micaela M., Piperno-Neumann, Sophie, Grossniklaus, Hans E., Kivelä, Tero T.

Volltext

Nivolumab in Previously Untreated Melanoma without BRAF Mutation von Robert, Caroline, Long, Georgina V, Brady, Benjamin, Dutriaux, Caroline, Maio, Michele, Mortier, Laurent, Hassel, Jessica C, Rutkowski, Piotr, McNeil, Catriona, Kalinka-Warzocha, Ewa, Savage, Kerry J, Hernberg, Micaela M, Lebbé, Celeste, Charles, Julie, Mihalcioiu, Catalin, Chiarion-Sileni, Vanna, Mauch, Cornelia, Cognetti, Francesco, Arance, Ana, Schmidt, Henrik, Schadendorf, Dirk, Gogas, Helen, Lundgren-Eriksson, Lotta, Horak, Christine, Sharkey, Brian, Waxman, Ian M, Atkinson, Victoria, Ascierto, Paolo A

Volltext

Five-Year Outcomes With Nivolumab in Patients With Wild-Type BRAF Advanced Melanoma von Robert, Caroline, Long, Georgina V., Brady, Benjamin, Dutriaux, Caroline, Di Giacomo, Anna Maria, Mortier, Laurent, Rutkowski, Piotr, Hassel, Jessica C., McNeil, Catriona M., Kalinka, Ewa Anna, Lebbe, Celeste, Charles, Julie, Hernberg, Micaela M., Savage, Kerry J., Chiarion-Sileni, Vanna, Mihalcioiu, Catalin, Mauch, Cornelia, Arance, Ana, Cognetti, Francesco, Ny, Lars, Schmidt, Henrik, Schadendorf, Dirk, Gogas, Helen, Zoco, Jesus, Re, Sandra, Ascierto, Paolo A., Atkinson, Victoria

Volltext

SAKK 35/14 RANDOMIZED TRIAL OF RITUXIMAB WITH OR WITHOUT IBRUTINIB FOR UNTREATED PATIENTS WITH ADVANCED FOLLICULAR LYMPHOMA IN NEED OF THERAPY von Østenstad, B., Pirosa, M. C., Schär, S., Brodtkorb, M., Wahlin, B. E., Hernberg, M., Pedersen, M., Stathis, A., Zander, T., Novak, U., Zenz, T., Fischer, N., Krasniqi, F., Hitz, F., Jjohansson, A., Lofgren, D., Meyer, P., Bjørnevik, A. T., Hayoz, S., Scheibe, B., Steiner, L., Dirnhofer, S., Ceriani, L., Zucca, E.

Volltext

Determinants of Long-Term Survival in Metastatic Choroidal and Ciliary Body Melanoma von Rantala, Elina S., Parrozzani, Raffaele, Hernberg, Micaela M., Chiarion-Sileni, Vanna, Kivelä, Tero T., Midena, Edoardo

Volltext

Two different durations of adjuvant therapy with intermediate-dose interferon alfa-2b in patients with high-risk melanoma (Nordic IFN trial): a randomised phase 3 trial von Hansson, Johan, Dr, Aamdal, Steinar, Prof, Bastholt, Lars, MD, Brandberg, Yvonne, Prof, Hernberg, Micaela, MD, Nilsson, Bo, MSc, Stierner, Ulrika, MD, von der Maase, Hans, Prof

Volltext

Health-related quality of life in patients with high-risk melanoma randomised in the Nordic phase 3 trial with adjuvant intermediate-dose interferon alfa-2b von Brandberg, Y, Aamdal, S, Bastholt, L, Hernberg, M, Stierner, U, von der Maase, H, Hansson, J

Volltext

PROGNOSTIC IMPLICATIONS OF THE MICROENVIRONMENT IN FOLLICULAR LYMPHOMA UNDER RITUXIMAB AND RITUXIMAB+LENALIDOMIDE THERAPY. A TRANSLATIONAL STUDY OF THE SAKK35/10 TRIAL von Menter, T., Tzankov, A., Zucca, E., Kimby, E., Vanazzi, A., Østenstad, B., Mey, U.J., Rauch, D., Wahlin, B., Hitz, F., Hernberg, M., Johansson, A., Nully Brown, P., Hagberg, H., Hawle, H., Hayoz, S., Dirnhofer, S.

Volltext

Sentinel lymph node biopsy and survival in elderly patients with cutaneous melanoma von Koskivuo, I., Hernberg, M., Vihinen, P., Virolainen, S., Talve, L., Seppänen, M., Vahlberg, T., Jahkola, T.

Volltext

Adjuvant Nivolumab versus Ipilimumab in Resected Stage III or IV Melanoma von Weber, Jeffrey, Mandala, Mario, Del Vecchio, Michele, Gogas, Helen J, Arance, Ana M, Cowey, C. Lance, Dalle, Stéphane, Schenker, Michael, Chiarion-Sileni, Vanna, Marquez-Rodas, Ivan, Grob, Jean-Jacques, Butler, Marcus O, Middleton, Mark R, Maio, Michele, Atkinson, Victoria, Queirolo, Paola, Gonzalez, Rene, Kudchadkar, Ragini R, Smylie, Michael, Meyer, Nicolas, Mortier, Laurent, Atkins, Michael B, Long, Georgina V, Bhatia, Shailender, Lebbé, Celeste, Rutkowski, Piotr, Yokota, Kenji, Yamazaki, Naoya, Kim, Tae M, de Pril, Veerle, Sabater, Javier, Qureshi, Anila, Larkin, James, Ascierto, Paolo A

Volltext

Interferon Alfa-2b Three Times Daily and Thalidomide in the Treatment of Metastatic Renal Cell Carcinoma von HERNBERG, Micaela, VIRKKUNEN, Pekka, BONO, Petri, AHTINEN, Henna, MÄENPÄÄ, Hanna, JOENSUU, Heikki

Volltext

Different expression of BRAFV600E, ALK and PD-L1 in melanoma in children and adolescents: a nationwide retrospective study in Finland in 1990-2014 von Rousi, Emma K., Koskivuo, Ilkka O., Juteau, Susanna M., Talve, Lauri A. I., Hernberg, Micaela M., Vihinen, Pia P., Kähäri, Veli-Matti

Volltext

PO-1554 Degraded 4 MeV electron beam in treating basal cell carcinoma: Safety study von Valve, A., Koskenmies, S., Anttonen, A., Nurmi, H., Hernberg, M., Tenhunen, M.

Volltext

Carl Blomqvist, Nordic network builder in oncology (1951-2023) von Hernberg, Micaela, Mattson, Johanna, Tenhunen, Mikko, Bergh, Jonas, Ahlgren, Johan, Holmberg, Lars, Sund, Malin, Nilbert, Mef

Volltext

Health-related quality of life (HRQOL) in the Nordic randomized trial of adjuvant intermediate-dose interferon alfa-2b in high-risk melanoma von Hansson, J., Aamdal, S., Bastholt, L., Hernberg, M., Nilsson, B., Stierner, U. K., von der Maase, H., Brandberg, Y.

Volltext

1092P Nivolumab plus relatlimab vs nivolumab in previously untreated metastatic or unresectable melanoma: 3-year subgroup analyses from RELATIVITY-047 von Schadendorf, D., Tawbi, H.A., Hodi, F.S., Lipson, E.J., Ascierto, P.A., Medina Soto, F.A., Maio, M., Hernberg, M., Mackiewicz, J., Prey, S., Mujika Eizmendi, M.K., Atkinson, V.G., Hassel, J.C., Cinat, G., Keidel, S., Rodriguez, S., Wang, P.T., Dolfi, S., Long, G.V.

Volltext

Long-Term Efficacy of a 6-Month Regimen of Rituximab and Lenalidomide in Follicular Lymphoma Patients in Need of First Therapy: Updated Analysis of the SAKK 35/10 Randomized Trial von Zucca, Emanuele, Schaer, Saemi, Vanazzi, Anna, Østenstad, Bjørn, Mey, Ulrich, Rauch, Daniel, Wahlin, Björn E., Hitz, Felicitas, Hernberg, Micaela, Johansson, Ann-Sofie, Brown, Peter de Nully, Hagberg, Hans, Ferreri, Andrés José María, Krasniqi, Fatime, Voegeli, Michèle, Novak, Urban, Zander, Thilo, Bersvendsen, Hanne, Mamot, Christoph, Mingrone, Walter, Stathis, Anastasios, Dirnhofer, Stefan, Hayoz, Stefanie, Kimby, Eva

Volltext